Project ECHO 200280 Study #DAKOS0009A
-
- STATUS
- Not Recruiting
Summary
The objective of the study is to establish a reasonable assurance of safety and effectiveness of HercepTest? mAb pharmDx as an aid in the assessment of breast cancer patients for whom Herceptin? (trastuzumab) PERJETA? (pertuzumab) or KADCYLA? (ado-trastuzumab emtansine) treatment is being considered.
Description
The objective of the study is to establish a reasonable assurance of safety and effectiveness of HercepTest? mAb pharmDx as an aid in the assessment of breast cancer patients for whom Herceptin? (trastuzumab) PERJETA? (pertuzumab) or KADCYLA? (ado-trastuzumab emtansine) treatment is being considered.
Details
| Condition | breast cancer |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX9000 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.